Drug Profile
Oxaliplatin liposomal - Regulon
Alternative Names: LipoxalLatest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator Regulon
- Class Antineoplastics; Platinum complexes; Small molecules
- Mechanism of Action DNA cross linking agents; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glioma
- Discontinued Colorectal cancer
Most Recent Events
- 27 Sep 2021 Discontinued - Phase-II for Colorectal cancer in Greece (IV) (Regulon website, September 2021)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Glioma in Greece (IV)
- 29 Dec 2014 Phase II development is ongoing